OCT 21, 2017 02:43 PM PDT

Understanding a Rare Liver Disorder so it can be Treated

WRITTEN BY: Carmen Leitch

Scientists have learned more about a genetic disorder that affects the liver; the work also reveals potential new therapeutic avenues for treating the disease, Alagille syndrome. The researchers, from Sanford Burnham Prebys Medical Discovery Institute (SBP), have found the genes and cells that make liver ducts in zebrafish. These ducts are thin tubes that transport bile, a critical digestive fluid, from the liver to the gallbladder and the small intestine. People that have Alagille syndrome don’t have the necessary number of liver ducts; jaundice, liver disease, and subsequent liver failure is the result.

This is Duc Dong, Ph.D., assistant professor in the Human Genetics Program, among zebrafish tanks. / Credit: SBP

Zebrafish are a convenient research model in biomedical research for many reasons, including in the study of this disorder. "We use zebrafish to study Alagille syndrome because these vertebrates allow us to use experimental approaches that aren't possible with other disease models," explained Duc Dong, Ph.D. Dong is an Assistant Professor in the Human Genetics Program at SBP and the senior author of a Nature Communications paper reporting these findings. "Organ development, especially the liver, is highly conserved among vertebrates - including zebrafish - and the mutations we create in zebrafish alter embryogenesis in a manner consistent with humans, making it an ideal model system to study diseases such as Alagille syndrome."

Mutations in a gene called Jagged1 cause Alagille syndrome; mutations in the Notch2 gene can also cause the disease but are responsible for under one percent of cases. It affects around one in 70,000 births, and the disease not only impacts the liver but also affects the blood vessels, heart, kidneys, and some other tissues. There is no treatment for the primary symptom of the disease - loss of liver ducts.

"We wanted to gain further insight into the way Jagged works during liver development," said Dong. "We already knew that Jagged triggers Notch signaling in neighboring cells - a key step in the development of many organs, including liver. But a deeper understanding of how Jagged regulates duct cell formation in livers could shape strategies to help fix these structures to potentially spare the 10 to 30 percent of patients that eventually need a liver transplant."

Mutant zebrafish allowed the research team to identify the origin of Jagged signals. The investigators were surprised to find the source was endoderm-derived cells in the liver, initiating, or failing to initiate, duct cell identity there. This result is different from that found using mice, which laid the blame on a lack of Jagged signaling from cells in hepatic veins. Dong's team has shown how Jagged triggers Notch activity directly, creating all liver duct cells.

"Our findings are important because knowing the location and specific cell type that require Jagged expression gives us the information we need to target therapeutics to the right place to compensate for the lack of Jagged function in Alagille syndrome,” explained Dong. "And with advances being made in gene therapy using technologies like CRISPR/Cas9, our discoveries put us closer to being able to deliver genetic corrections of Jagged1 mutations.

"Because duct cells are lost due to a lack of Jagged function, and are not just malformed as previously thought, we now need to also consider regenerative therapeutic approaches to replace duct cells lost in this disease. Indeed, we have unpublished data suggesting that duct cells can regenerate when we allow normal Jagged function to resume."

"We are also exploring the possibility of using zebrafish to identify potential drugs that could alleviate pathologies caused by loss of Jagged function," Dong continued. "In fact, we are now gearing up for a chemical screen and working on finding funding for this project."

"This study shows the value in studying alternative disease models. In this case, zebrafish were critical for advancing our understanding of Jagged function in the liver, allowing us to devise new therapeutic strategies for Alagille Syndrome."

Sources: AAAS/Eurekalert! Via Sanford Burnham Prebys Medical Discovery Institute, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 14, 2019
Genetics & Genomics
DEC 14, 2019
Gaining New Insight Into ALS and Other Neurodegenerative Disorders
Scientists have now used a technique called deep mutagenesis to reveal more about amyotrophic lateral sclerosis....
DEC 14, 2019
Genetics & Genomics
DEC 14, 2019
Genetic Variations Connected to Severe Forms of Multiple Sclerosis
Scientists are learning more about the genetic factors underlying MS, which is a highly variable disease....
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Gene Variant Could Be a Therapeutic Target For Alzheimer Disease
A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The in...
DEC 14, 2019
Genetics & Genomics
DEC 14, 2019
Don't Like Vegetables? It Could be Genetic
Don’t like eating vegetables? Researchers from the University of Kentucky (UKY) have found that the reason why may be genetic.  Humans carry two...
DEC 14, 2019
Genetics & Genomics
DEC 14, 2019
An Epigenetic Switch Changes Warrior Ants Into Foragers
Researchers were able to change the behavior of a type of carpenter ant, and now they know the biological basis for the change....
DEC 14, 2019
Cell & Molecular Biology
DEC 14, 2019
Newly Identified Small Proteins Could Have a Big Impact
While the human genome has been sequenced, there are plenty of parts of it that we don't know much about....
Loading Comments...